63 / 164
323
RJ. Pleural procedures and pleuroscopy. Respirology 2009
796-807.
12. Feller-Kopman D, Berkowitz D, Boiselle P, and Ernest A. Large-
Volume Thoracentesis and the Risk of Reexpansion Pulmonary
Edema. Ann Thorac Surg 2007;84:1656–62.
13. Eisen L. Thoracentesis. NEJM 2007; 356:641-642.
14. Feller-Kopman D, Walkey A, Berkowitz D, Ernst A. The relationship
of pleural pressure to symptom development during therapeutic
thoracentesis. Chest. 2006 Jun; 129(6): 1556 – 60.
15. Matin T, Gleeson F. Interventional radiology of pleural diseases.
Respirology (2011) 16, 419–429.
16. Light RW, MacGreggor I, Luchsinger PC, et al. Pleural effusions:
the diagnostic separation of transudates and exudates. Ann
Intern Med 1972;77:507-13.
17. Villena V, Ferrer J, Hernández L, De Pablo A, Pérez F, Rodríguez-
Panadero F, Romero S, Salvatierra A, y Valdés L. Área de Técnicas
y Trasplante. SEPAR. Diagnóstico y tratamiento del derrame
pleural. Arch Bronconeumol 2006; 42(7):349-72.
18. Bielsa S, Porcel JM, Castellote J, Mas E, Esquerda A, and Light
RW. Solving the Light's criteria misclassification rate of cardiac
and hepatic transudates. Respirology 2012, 17 721-726.
19. Long AC, O'Neal HR, Peng S, Lane KB, and Light RW. Comparison
of Pleural Fluid N-Terminal Pro-Brain Natriuretic Peptide and
Brain Natriuretic-32 Peptide Levels . Inter Med 2008, 1669-
1674.
20. Saguil A, Wyrick K, and Hallgren J. Diagnostic Approach to
pleural Effusion. Am Fam Physician. 2014;90(2):99-104.
21. Porcel JM. The Diagnostic Utility of Pleural Fluid Tests in Clinical
Practice. Current Respiratory Medicine Reviews, 2012, 8,
383-390.
22. Krenke R, J. Nasilowski, Korczynski P, Gorska K, Przybylowski T,
Chazan R, and Light RW. Incidence and aetiology of eosinophilic
pleural effusion. Eur Respir J 2009; 34: 1111–1117.
23. Rahman NM. Investigation of the patient with pleural effusion.
Clin Med 2009; 9:174-178 .
24. Rooper LM, Ali SZ, Olson MI. A minimum fluid volume of 75 mL
in needed to ensure Adecuacy in pleural effusion: a Retrospective
Analysis of 2450 cases. Cancer Cytopathol 2014;122:657-65.
25. Rodríguez-Panadero F. Revisión y Puesta al Día En Patología
Pleural. Rev española patologia torácica 2010, 22 142-166.
26. Tsai TH, Wu SG, Chang YL, Wu CT, Tsai MF, Wei PF, et al.Effusion
immunocytochemistry as an alternative approach for the
selection of first-line targeted therapy in advanced lung
adenocarcinoma. J Thorac Oncol J 2012 Jun;7(6):993-1000.
27. Rahman NM, Mishra EK, Davies RJ. Davies HE, and Lee YC.
Clinically Important Factors Influencing the Diagnostic
Measurement of Pleural Fluid pH and Glucose. Am J Respir Crit
Care Med Vol 178. pp 483–490, 2008.
28. Davies HE, Davies RJ, Davies CW, on behalf of the BTS Pleural
Disease Guideline Group. Thoracic Society pleural disease
guideline 2010. Management of pleural infection in adults:
British. Thorax 2010;65(Suppl 2):ii41eii53.
29. Light R. Update on tuberculous pleural effusion. Respirology
(2010) 15, 451–458.
30. Krenke R, Korczynski P. Use of pleural fluid levels of adenosine
deaminase and interferon gamma in the diagnosis of tuberculous
pleuritis. Curr opin 2010: 367-375.
31. Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of
adenosine deaminase activity in pleural fluid: a single-center
experience with over 2100 consecutive patients. Eur J Intern
Med). 2010 Oct;21(5):419-23.
32. Trajman A, Pai M, Dheda K, Van Zyl Smit R, Zwerling AA, Joshi
R, et al. Novel tests for diagnosing tuberculous pleural effusion:
what works and what does not?. Eur Respir J 2008; 31: 1098–
1106.
33. Doosoo J. Tuberculous Pleurisy: An Update. tuberc Respir Dis
2014;76:153-159.
34. Ferreiro L, Toubes ME, Valdés L. Contribution of pleural fluid
analysis to the diagnosis of pleural effusion. Med Clin (Barc).
2014 Nov 26. pii: S0025-7753(14)00659-9.
35. Pantazopoulos I, Boura P, Xanthos T, and Syrigos K. Effectiveness
of mesothelin family proteins and osteopontin for malignant
mesothelioma. Eur Respir J 2013; 41: 706–715.
36. Hollevoet K, Reitsma JB, Creaney J, Grigoriu BD, Robinson BW,
Scherpereel A, et al. Serum mesothelin for diagnosing malignant
pleural mesothelioma: an individual patient data meta-
analysis. J Clin Oncol. 2012 May 1;30(13):1541-9.
37. Rodriguez-Panadero F, Romero-Romero B. Current and future
options for the diagnosis of malignant pleural effusion. Expert
Opin Med Diagn. 2013 May;7(3):275-87.
38. Martín J. Técnicas de biopsia en patología pleural. Neumosur
2006; 18, 3: 137-142.
39. Canto A, Rivas J, Saumench J, Morera R, and Moya J. Points to
Consider When Chosing A Biopsy Method in Cases of Pleurisy of
Unknown Origin. Chest. 1983;84(2):176-179.
40. Diacon AH, Van de Wal BW, Wyser C, Smedema JP, Bezuidenhout
J, Bolliger CT, Walzl G. Diagnostic tools in tuberculous pleurisy: a
direct comparative study. Eur Respir J 2003; 22: 589–591.
41. Janssen JP. Why you do or do not need thoracoscopy. Eur Respir
Rev 2010; 19: 117, 213-216.
42. Cao, Y., Fan, N., Xing, F., Xu, L., Qu, Y., & Liao, M. Computed
tomography-guided cutting needle pleural biopsy: Accuracy
and complications. Experimental and therapeutic medicine 9:
262-266, 2015.
43. Diacon AH, Schuurmans MM.,Theron J, Schubert PT, Wright CA,
Bolliger CT. Safety and Yield of Ultrasound-Assisted Transthoracic
Biopsy Performed by Pulmonologists. Respiration 2004;71:519–
522.
44. Lee P, Colt HG. Pleuroscopy in 2013Clin Chest Med 34 (2013)
81–91.
45. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ, on behalf
of the BTS Pleural Disease Guideline Group Management of
a malignant pleural effusion: British Thoracic Society pleural
disease guideline 2010 Thorax 2010;65(Suppl 2):ii32eii40.
46. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions.
Cochrane Database Syst Rev 2004; 1:CD002916.
47. Rodriguez-Panadero F. and Montes-Worboys A: Mechanisms of
pleurodesis. Respiration 83: 91-98, 2012.
[Enfoque diagnóstico en el paciente con derrame pleural-Dra. Maite Oyonarte W.]